Tissue-nonspecific Alkaline Phosphatase [EPC]

10322 reported adverse events

Drugs of this class: ASFOTASE ALFA

These side effects are most commonly reported by patients taking drugs of the Tissue-nonspecific Alkaline Phosphatase [EPC] class:

# Side effect Count
0 INJECTION SITE PAIN 1351
1 FATIGUE 1029
2 INJECTION SITE ERYTHEMA 881
3 PAIN 851
4 INJECTION SITE REACTION 778
5 ARTHRALGIA 713
6 PAIN IN EXTREMITY 564
7 INJECTION SITE BRUISING 513
8 INJECTION SITE SWELLING 442
9 HEADACHE 416
See all common reactions for Tissue-nonspecific Alkaline Phosphatase [EPC]

Drugs of the Tissue-nonspecific Alkaline Phosphatase [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VITAMIN B6 DECREASED 166 0.6510
1 VITAMIN B6 INCREASED 91 0.4550
2 BLOOD ALKALINE PHOSPHATASE DECREASED 113 0.1191
3 INJECTION SITE ATROPHY 166 0.1009
4 LIPODYSTROPHY ACQUIRED 86 0.0405
5 CALCINOSIS 77 0.0344
6 INJECTION SITE DISCOLOURATION 267 0.0213
7 BLOOD ALKALINE PHOSPHATASE INCREASED 319 0.0128
8 INJECTION SITE REACTION 778 0.0113
9 VITAMIN D DECREASED 95 0.0111
See all enriched reactions for Tissue-nonspecific Alkaline Phosphatase [EPC]